Longitudinal assessment of systemic steroid therapy on hyperinflammatory endothelial biomarker profiles and serology responses of COVID-19 patients.
作者信息
Sims Jonathan T, Chang Ching-Yun, Poorbaugh Josh, Daniels Montanea, Beasley Stephanie L, Zhang Lin, Rodgers George H, Lena Fabio, Lacerenza Leonardo G, Sposato Bruno, Dupont Annabelle, Susen Sophie, Casalini Giacomo, Corbellino Mario, Stebbing Justin, Krishnan Venkatesh
机构信息
Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Department of Pharmaceutical Medicine, Misericordia Hospital, Grosseto, Italy.
出版信息
J Transl Med. 2022 Sep 8;20(1):411. doi: 10.1186/s12967-022-03583-5.
Abstract
摘要
相似文献
1
Longitudinal assessment of systemic steroid therapy on hyperinflammatory endothelial biomarker profiles and serology responses of COVID-19 patients.全身类固醇疗法对COVID-19患者高炎症性内皮生物标志物谱和血清学反应的纵向评估。
J Transl Med. 2022 Sep 8;20(1):411. doi: 10.1186/s12967-022-03583-5.
2
Dexamethasone may improve severe COVID-19 via ameliorating endothelial injury and inflammation: A preliminary pilot study.地塞米松可能通过改善内皮损伤和炎症来改善严重 COVID-19：初步试点研究。
PLoS One. 2021 Jul 2;16(7):e0254167. doi: 10.1371/journal.pone.0254167. eCollection 2021.
3
Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab.新冠病毒疾病（COVID-19）住院患者经中和单克隆抗体巴尼韦单抗治疗后，鼻咽拭子基因表达模式与血清生物标志物之间的关系。
J Transl Med. 2022 Mar 18;20(1):134. doi: 10.1186/s12967-022-03345-3.
4
Steroid therapy and antiviral treatment in SARS-CoV-2 pneumonia: clinical contexts and indications.类固醇治疗和抗病毒治疗在 SARS-CoV-2 肺炎中的应用：临床情况和适应证。
Rev Esp Quimioter. 2022 Apr;35 Suppl 1(Suppl 1):54-58. doi: 10.37201/req/s01.13.2022. Epub 2022 Apr 22.
5
Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19.细胞因子风暴的特征反映了 COVID-19 中的过度炎症性内皮功能障碍。
J Allergy Clin Immunol. 2021 Jan;147(1):107-111. doi: 10.1016/j.jaci.2020.08.031. Epub 2020 Sep 10.
6
A Comparison of the Efficacy of Adjuvant Parenteral Methylprednisolone and Dexamethasone in Reducing Covid-19 Disease Severity and Mortality among the Moderate to Critical Patients -A Retrospective Study.辅助性肌内注射甲泼尼龙和地塞米松治疗中重度至危重症 COVID-19 患者的疗效比较：一项回顾性研究。
J Assoc Physicians India. 2022 Apr;70(4):11-12.
7
Good response of low-dose steroid in a patient with COVID-19 pneumonia and autoimmune disease.低剂量类固醇对一名新冠肺炎合并自身免疫性疾病患者的良好疗效。
J Microbiol Immunol Infect. 2021 Oct;54(5):1001-1002. doi: 10.1016/j.jmii.2021.04.005. Epub 2021 May 12.
8
SARS-CoV-2 Infection in Spondyloarthritis Patients Treated With Biotechnological Drugs: A Study on Serology.接受生物技术药物治疗的脊柱关节炎患者的新型冠状病毒2型感染：一项血清学研究
Front Immunol. 2021 Jun 11;12:682850. doi: 10.3389/fimmu.2021.682850. eCollection 2021.
9
Covid-19 and leptospirosis: Cytokine storm and the use of steroids.Covid-19 和钩端螺旋体病：细胞因子风暴与类固醇的使用。
Trop Doct. 2021 Jan;51(1):128-130. doi: 10.1177/0049475520971425. Epub 2020 Nov 25.
10
Treatment of severe COVID-19: an evolving paradigm.严重 COVID-19 的治疗：不断变化的范式。
Expert Opin Pharmacother. 2022 Dec;23(17):1887-1891. doi: 10.1080/14656566.2022.2140041. Epub 2022 Oct 28.
引用本文的文献
1
Serum IL-6 and PTX3 predict severe outcome from COVID-19 in ambulatory subjects: Impact for future therapeutic decisions.血清白细胞介素-6和PTX3可预测门诊COVID-19患者的严重预后：对未来治疗决策的影响。
PLoS One. 2025 May 27;20(5):e0324242. doi: 10.1371/journal.pone.0324242. eCollection 2025.
本文引用的文献
1
Targeting ACE2 for COVID-19 Therapy: Opportunities and Challenges.针对 COVID-19 治疗的 ACE2 靶点：机遇与挑战。
Am J Respir Cell Mol Biol. 2021 Apr;64(4):416-425. doi: 10.1165/rcmb.2020-0322PS.
2
Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19.纵向蛋白质组学分析揭示了重症 COVID-19 中早期炎症和持续凋亡蛋白的增加。
Sci Rep. 2020 Nov 25;10(1):20533. doi: 10.1038/s41598-020-77525-w.
3
Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19.细胞因子风暴的特征反映了 COVID-19 中的过度炎症性内皮功能障碍。
J Allergy Clin Immunol. 2021 Jan;147(1):107-111. doi: 10.1016/j.jaci.2020.08.031. Epub 2020 Sep 10.
4
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.新型冠状病毒病中“细胞因子风暴”的发病机制与治疗。
J Infect. 2020 Jun;80(6):607-613. doi: 10.1016/j.jinf.2020.03.037. Epub 2020 Apr 10.
Zotero 插件